Outpatient opioid use after minimally invasive surgery for lung cancer: a Surveillance, Epidemiology, and End Results-Medicare cohort study
Alyssa Murillo, Gediwon Milky, Tessa Runels, I-Fan Shih, Daniel S Oh, Johannes R Kratz · 2025
Read Outpatient opioid use after minimally invasive surgery for lung cancer: a Surveillance, Epidemiology, and End Results-Medicare cohort study by Alyssa Murillo, Gediwon Milky, Tessa Runels, I-Fan Shih, Daniel S Oh, Johannes R Kratz (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12688600.txt.
Description
A peer-reviewed research article from Europe PMC (2025). BackgroundOpioids are commonly used for postoperative pain after lung resection. It is unclear whether opioid use differs between minimally invasive thoracoscopic approaches. We compared opioid use following robotic-assisted surgery (RAS) and video-assisted thoracoscopic surgery (VATS).MethodsThe Surveillance, Epidemiology, and End Results-Medicare claims database was queried for patients who underwent resection of non-small cell lung cancer (NSCLC) between January 2016 and July 2020.
Catalog record
| CREATOR | Alyssa Murillo, Gediwon Milky, Tessa Runels, I-Fan Shih, Daniel S Oh, Johannes R Kratz |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |